DCYHF:OTC-Discovery Limited (USD)

COMMON STOCK | Insurance - Life |

Last Closing

USD 7.05

Change

0.00 (0.00)%

Market Cap

USD 6.75B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-18 )

Largest Industry Peers for Insurance - Life

Symbol Name Price(Change) Market Cap
MET MetLife Inc

+0.80 (+1.13%)

USD 53.21B
AFL Aflac Incorporated

+0.92 (+1.10%)

USD 48.66B
MET-PA MetLife Inc Preferred Stock Se..

-0.07 (-0.29%)

USD 46.72B
MFC Manulife Financial Corp

+0.25 (+1.07%)

USD 44.17B
MET-PE MetLife Inc Preferred Stock Se..

+0.12 (+0.51%)

USD 41.61B
PRU Prudential Financial Inc

+1.82 (+1.65%)

USD 39.42B
PUK Prudential Public Limited Comp..

+0.23 (+1.31%)

USD 25.10B
GL Globe Life Inc

+3.31 (+4.35%)

USD 10.94B
UNM Unum Group

+1.17 (+2.31%)

USD 10.29B
PRI Primerica Inc

+3.65 (+1.72%)

USD 7.71B

ETFs Containing DCYHF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Insurance - Life) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return 18.44% 100% F 100% F
Total Return 18.44% 95% A 93% A
Trailing 12 Months  
Capital Gain -12.42% 15% F 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -12.42% 15% F 17% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.30% 63% D 44% F
Dividend Return 2.30% 47% F 39% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 25.66% 59% D- 78% C+
Risk Adjusted Return 8.98% 47% F 44% F
Market Capitalization 6.75B 44% F 80% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.